WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer, today announced that Company management will provide a corporate update and review of the first quarter 2009 results via webcast and conference call on Tuesday, May 5, 2009 at 4:30 p.m. ET.
